Leishmania vaccine using sand fly salivary immunogen
US8603808B2 · kind B2 · utility
1Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 6, 2009 |
| Grant date | Dec 10, 2013 |
| Priority date | — |
| Expiry date | Dec 18, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides vectors that contain and express in vivo or in vitro sand fly Lu. longipalpis salivary antigens that elicit an immune response in animal or human against Leishmania, vaccine compositions comprising said vectors and/or Lu. longipalpis salivary polypeptides, methods of vaccination against Leishmania, and kits for use with such methods and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.